Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China - Top-Institutions - MDSpire

Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China

  • By

  • Hongzhan Cui

  • Jiao Wang

  • Tengyue Zhao

  • Hongjuan Liao

  • Jieqiong Zhang

  • Luyu Li

  • Ce Feng

  • Hongyu Xiao

  • Jialu Li

  • Ziying Chen

  • June 15, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Second Hospital of Hebei Medical University
    Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei

    Key Differentiators

    • Cardiology

  • #2

    Qilu Hospital of Shandong University
    Qilu Hospital of Shandong University

    Jinan, Shandong

    Key Differentiators

    • Cardiology

  • #3

    University Medical Centre Mainz
    University Medical Centre Mainz

    Mainz, Rhineland-Palatinate

    Key Differentiators

    • Cardiology

  • #4

    Cipto Mangunkusumo Hospital
    Cipto Mangunkusumo Hospital

    Jakarta, Jakarta

    Key Differentiators

    • Cardiology

  • #5

    University Hospital Tübingen
    University Hospital Tübingen

    Tübingen, Baden-Württemberg

    Key Differentiators

    • Cardiology

Original Source(s)

Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China

  • by Hongzhan Cui, Jiao Wang, Tengyue Zhao, Hongjuan Liao, Jieqiong Zhang, Luyu Li, Ce Feng, Hongyu Xiao, Jialu Li, Ziying Chen

  • June 15, 2026

Related Content

Correction: Association between adjusted body size index and abdominal aortic calcification among US older adults aged 40 years and above from a cross-sectional survey of the NHANES 2013–2014

Editorial: Environmental determinants of cardiovascular health: interactions with lifestyle and socioeconomic factors

Emergency criteria and lifesaving intervention windows for high-risk critical congenital heart disease: a perspectives